Albumin: don't confuse us with the facts. Rather than fulminating, seek to answer the questions raised.
作者信息
McClelland B
出版信息
BMJ. 1998 Sep 26;317(7162):829-30. doi: 10.1136/bmj.317.7162.829.
Abstract
摘要
相似文献
1
Albumin: don't confuse us with the facts. Rather than fulminating, seek to answer the questions raised.白蛋白：别用事实来误导我们。与其大发雷霆，不如试着回答提出的问题。
BMJ. 1998 Sep 26;317(7162):829-30. doi: 10.1136/bmj.317.7162.829.
2
Human albumin administration in critically ill patients. I would not want an albumin transfusion.危重症患者输注人白蛋白。我不想输注白蛋白。
BMJ. 1998 Sep 26;317(7162):885.
3
Human albumin administration in critically ill patients. Some patients may benefit.在危重症患者中输注人白蛋白。部分患者可能获益。
BMJ. 1998 Sep 26;317(7162):885-6.
4
Adverse effects of albumin--uncertain times.白蛋白的不良反应——不确定的时代。
Med J Aust. 1999 Apr 19;170(8):398-9. doi: 10.5694/j.1326-5377.1999.tb139189.x.
5
Human albumin administration in critically ill patients. Paper failed to mention earlier review.危重症患者使用人白蛋白。该论文未提及早期综述。
BMJ. 1998 Sep 26;317(7162):884.
6
7
8
9
Human albumin administration in critically ill patients. Validity of review methods must be assessed.危重症患者使用人白蛋白。必须评估综述方法的有效性。
BMJ. 1998 Sep 26;317(7162):883-4.
10
Consider validity, clinical relevance, and applicability of albumin for critically ill patients.考虑白蛋白对重症患者的有效性、临床相关性和适用性。
BMJ. 1998 Aug 1;317(7154):343. doi: 10.1136/bmj.317.7154.343.
引用本文的文献
1
From conflict to controversy: the use and abuse of human albumin solutions after the Second World War.从冲突到争议：二战后人类白蛋白溶液的使用与滥用
Anaesth Intensive Care. 2023 Nov;51(6):368-371. doi: 10.1177/0310057X231199368.
2
Guidelines for the clinical use of albumin: comparison of use in two Italian hospitals and a third hospital without guidelines.白蛋白临床使用指南：两家意大利医院与一家无指南的第三家医院的使用情况比较
Curr Ther Res Clin Exp. 2003 Nov;64(9):676-84. doi: 10.1016/j.curtheres.2003.11.002.
3
Efficacy of albumin in critically ill patients.白蛋白对重症患者的疗效。
BMJ. 2003 Mar 15;326(7389):559-60. doi: 10.1136/bmj.326.7389.559.
4
More on albumin. Use of human albumin in UK fell substantially when systematic review was published.更多关于白蛋白的内容。当一项系统评价发表后，英国人体白蛋白的使用量大幅下降。
BMJ. 1999 May 1;318(7192):1214-5. doi: 10.1136/bmj.318.7192.1214b.
本文引用的文献
1
Human albumin administration in critically ill patients. Evidence needs to be shown in paediatrics.危重症患者使用人白蛋白。儿科领域需提供证据。
BMJ. 1998 Sep 26;317(7162):882.
2
Fluid resuscitation with colloid or crystalloid solutions. One conclusion could be that hypertonic saline is better than colloids in trauma.使用胶体或晶体溶液进行液体复苏。一个结论可能是，在创伤治疗中高渗盐水比胶体更好。
BMJ. 1998 Jul 25;317(7153):277-8; author reply 279.
3
Giving albumin increases mortality in critically ill patients.给予白蛋白会增加危重症患者的死亡率。
BMJ. 1998 Jul 25;317(7153):A.
4
Human albumin administration in critically ill patients: systematic review of randomised controlled trials.危重症患者使用人白蛋白：随机对照试验的系统评价
BMJ. 1998 Jul 25;317(7153):235-40. doi: 10.1136/bmj.317.7153.235.
5
Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials.危重症患者使用胶体液或晶体液进行液体复苏：随机试验的系统评价
BMJ. 1998 Mar 28;316(7136):961-4. doi: 10.1136/bmj.316.7136.961.
6
Use of blood products for elective surgery in 43 European hospitals. The Sanguis Study Group.43家欧洲医院择期手术中血液制品的使用情况。桑吉斯研究小组。
Transfus Med. 1994 Dec;4(4):251-68.
7
Wonderful albumin?神奇的白蛋白？
BMJ. 1995 Apr 8;310(6984):887-8. doi: 10.1136/bmj.310.6984.887.
8
Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I.住院患者不良事件和过失的发生率。哈佛医疗实践研究I的结果。
N Engl J Med. 1991 Feb 7;324(6):370-6. doi: 10.1056/NEJM199102073240604.
Zotero 插件